Purchase Order HHSN265201800043M

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. for $18,421.00 on December 10, 2019, with ultimate completion on December 10, 2020.</p> <p>Work is performed at the awardee's facility in Pleasanton, California. The order is firm fixed price with no set-aside. The source does not specify the particular genomic instruments, reagents, or consumables procured under this order.</p>

The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $6,909.00 on May 1, 2018, for firm fixed price delivery with an ultimate completion date of April 30, 2019. Place of performance is Pleasanton, California. No set-aside was used. The order is for genomic analysis instruments, consumables, or bioinformatics software within 10X Genomics' core product portfolio of single-cell and spatial transcriptomics platforms and associated...

The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. on December 28, 2020, for $11,864.00 under firm fixed price terms. Performance occurs in Pleasanton, California. The purchase order calls for genomic analysis platforms, reagents, or related consumables aligned with the vendor's product portfolio of single-cell and spatial transcriptomics technologies supporting neurological disease research. Ultimate completion was scheduled for January...

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $5,500 on May 24, 2018. Place of performance is Pleasanton, California. The order procures genomic analysis instruments, consumables, or reagents under firm fixed price terms. Ultimate completion date is May 23, 2019.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. for $10,949.72 on April 2, 2021. The order, issued under firm fixed pricing, covers genomic analysis reagents and consumables supplied from the vendor's Pleasanton, California facility. The ultimate completion date was April 2, 2021.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $12,521.00 on January 16, 2019, for firm fixed price commercial items with no set-aside designation. Work is performed at the vendor's facility in Pleasanton, California. The order was ultimately completed on January 15, 2020.</p>

<p>The National Institute on Aging awarded a purchase order to 10X Genomics, Inc. valued at $20,347.00 on June 16, 2017, with ultimate completion on July 16, 2017. The order is a firm fixed price acquisition with no set-aside. Work is performed in Baltimore, Maryland. The purchase order procures genomic analysis instruments, consumables, or reagent kits from 10X Genomics' single-cell and spatial transcriptomics platform portfolio.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $26,520.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X multiple kits for genomics 5 GEMS library preparation. The place of performance is Pleasanton, California. The period of performance is from August 17, 2023 through August 22, 2023. This purchase order was awarded under an existing NIH vehicle to support the agency's genomics research...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. for $20,773.65 on September 18, 2018, with completion targeted for September 17, 2019. The order is firm fixed price with no set-aside designation. Performance takes place in Pleasanton, California. The purchase order procures specialized genomic analysis kits and reagents, which represent 10X Genomics' core product offerings in single-cell and spatial transcriptomics technologies for...